UK markets close in 5 hours 32 minutes

Hims & Hers Health, Inc. (HIMS)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
11.65+0.39 (+3.46%)
At close: 04:00PM EDT
13.48 +1.83 (+15.71%)
Pre-market: 05:56AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.50B
Enterprise value 2.29B
Trailing P/E N/A
Forward P/E 116.28
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.80
Price/book (mrq)7.27
Enterprise value/revenue 2.63
Enterprise value/EBITDA -114.84

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 35.73%
S&P500 52-week change 324.49%
52-week high 317.16
52-week low 35.65
50-day moving average 313.89
200-day moving average 39.24

Share statistics

Avg vol (3-month) 35.51M
Avg vol (10-day) 34.52M
Shares outstanding 5206.27M
Implied shares outstanding 6214.79M
Float 8185.95M
% held by insiders 111.73%
% held by institutions 157.48%
Shares short (15 Apr 2024) 417.47M
Short ratio (15 Apr 2024) 43.58
Short % of float (15 Apr 2024) 49.29%
Short % of shares outstanding (15 Apr 2024) 48.14%
Shares short (prior month 15 Mar 2024) 412.76M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -0.25%
Operating margin (ttm)3.56%

Management effectiveness

Return on assets (ttm)-0.73%
Return on equity (ttm)-0.71%

Income statement

Revenue (ttm)959.4M
Revenue per share (ttm)4.55
Quarterly revenue growth (yoy)45.80%
Gross profit (ttm)N/A
EBITDA 5.56M
Net income avi to common (ttm)-2.35M
Diluted EPS (ttm)-0.11
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)203.59M
Total cash per share (mrq)0.95
Total debt (mrq)11.82M
Total debt/equity (mrq)3.43%
Current ratio (mrq)2.81
Book value per share (mrq)1.61

Cash flow statement

Operating cash flow (ttm)89.84M
Levered free cash flow (ttm)55.69M